Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

April 16 2024 - J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales

J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales
Ukraine was pharma’s ‘darling’ of clinical trials. As war drags on, will the industry come back?
Humira biosimilar scripts take off
Intra-Cellular launches 26% to record high, breaking out after depression drug scores big
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bayer Seeks Approval for Xarelto

Yahoo/Zacks.com

Thursday, January 6, 2011 - 12:36pm

tags:

Bayer, Xarelto, JNJ, Pfizer, Bristol-Myers Squibb, blood thinners

Seattle Genetics in $8M deal with Pfizer

Bizjournals.com

Thursday, January 6, 2011 - 12:16pm

tags:

Pfizer, Seattle Genetics, ADC products

How Managing Decline Is Becoming a Key Skill in the Drug Business

BNET Pharma

Thursday, January 6, 2011 - 8:04am

tags:

Basilea Rises Most in 11 Months on Takeover Speculation

Bloomberg

Thursday, January 6, 2011 - 8:02am

tags:

The World's Most-Watched Pharma

Motley Fool

Thursday, January 6, 2011 - 8:01am

tags:

JNJ, Pfizer, Abbott Laboratories, Merck, Teva Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly

Inspire Pharmaceuticals: Looking for Inspiration Following Denufosol Failure

Seeking Alpha

Thursday, January 6, 2011 - 7:43am

tags:

Inspire, denufosol, cystic fibrosis

Why Cerus Is My Stock of the Year

Motley Fool

Thursday, January 6, 2011 - 7:42am

tags:

Merck Ends Drug Research Pact With Ranbaxy, Economic Times Says

Bloomberg

Thursday, January 6, 2011 - 7:41am

tags:

Spectrum Pharma Jumps in With the Big Dogs

Motley Fool

Thursday, January 6, 2011 - 7:40am

tags:

Spectrum Pharmaceuticals, Roche, biosimilars, Biogen Idec, Rituxan

Roche Wins Broader U.S. Approval for Actemra Arthritis Drug

Bloomberg

Thursday, January 6, 2011 - 7:39am

tags:

Actemra, Roche, arthritis

Does United Therapeutics Miss the Grade?

Motley Fool

Thursday, January 6, 2011 - 7:33am

tags:

United Therapeutics, Teva Pharmaceuticals, GSK, Pfizer

A Pregnant Pause Over A Merck Contraceptive

Pharmalot

Wednesday, January 5, 2011 - 12:12pm

tags:

Merck, Implanon, UK, contraceptives

Birmingham court to oversee nearly 1200 Pfizer lawsuits over Chantix

Birmingham News, AL

Wednesday, January 5, 2011 - 11:51am

tags:

Alabama, Pfizer, Chantix, lawsuits, smoking cessation

Mann doubles down on biotech as Afrezza decision looms

Fierce Biotech

Wednesday, January 5, 2011 - 11:49am

tags:

diabetes, MannKind, inhaled insulin, Afrezza

Will hedge funds back pharma whistleblowers?

Fierce Pharma

Wednesday, January 5, 2011 - 11:44am

tags:

hedge funds, whistleblowers, GSK

Avastin raises heart failure risk in breast cancer

Reuters

Wednesday, January 5, 2011 - 11:43am

tags:

Roche, Avastin, heart failure, breast cancer

Drug indexes dip; Sinovac falls on downgrade

Marketwatch

Wednesday, January 5, 2011 - 11:42am

tags:

Sinovac, drug stocks

Will the Neudexta Launch Transform Avanir Into a Mature Biotech?

Seeking Alpha

Wednesday, January 5, 2011 - 11:42am

tags:

Neudexta, Avanir, PBA

Opexa soars on talks with FDA over MS drug

Marketwatch

Wednesday, January 5, 2011 - 11:10am

tags:

FDA, MS, Opexa, multiple sclerosis, Tovaxin

Biotech 2011 Kickoff Party: Investor Preview

TheStreet.com

Wednesday, January 5, 2011 - 11:09am

tags:

biotech, Celgene, Dendreon, MannKind, Vertex Pharmaceuticals, Genzyme, Ariad Pharmaceuticals, Keryx

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition

Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study

Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sapio Sciences launches new drug discovery platform

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

How Patient Engagement Can Reduce Brand Launch Risks

Drug Channels

The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead

Drug Channels

SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025

Drug Channels

Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)

Drug Channels

Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)

Drug Channels

The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)

Drug Channels

What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)

Drug Channels

Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s (rerun)

Drug Channels

Navigating Market Access Challenges in Life Sciences Commercialization

Drug Channels